Login / Signup

Bisphosphonates hinder osteoblastic/osteoclastic differentiation in the maxillary sinus mucosa-derived stem cells.

Jun ZhangJaesuh ParkJung-Woo LeeYong-Dae KwonEun-Cheol Kim
Published in: Clinical oral investigations (2017)
It suggests that patients taking BPs during the period of maxillary sinus lifting and amentation should be given special attention.
Keyphrases
  • stem cells
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • cell therapy
  • mesenchymal stem cells